Display options
Cite
He J, Kraft AJ, Fan J, et al. Simultaneous Detection of CDC Category "A" DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays. Viruses. 2009;1(3):441-459doi: 10.3390/v1030441.
He, J., Kraft, A. J., Fan, J., Van Dyke, M., Wang, L., Bose, M. E., Khanna, M., Metallo, J. A., & Henrickson, K. J. (2009). Simultaneous Detection of CDC Category "A" DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays. Viruses, 1(3), 441-459. https://doi.org/10.3390/v1030441
He, Jie, et al. "Simultaneous Detection of CDC Category "A" DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays." Viruses vol. 1,3 (2009): 441-459. doi: https://doi.org/10.3390/v1030441
He J, Kraft AJ, Fan J, Van Dyke M, Wang L, Bose ME, Khanna M, Metallo JA, Henrickson KJ. Simultaneous Detection of CDC Category "A" DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays. Viruses. 2009;1(3):441-459. doi: 10.3390/v1030441. PMID: 20224751; PMCID: PMC2836126.
Copy Download .nbib Format: NLM
Share it on

Viruses. 2009;1(3):441-459. doi: 10.3390/v1030441.

Simultaneous Detection of CDC Category "A" DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays.

Viruses

Jie He, Andrea J Kraft, Jiang Fan, Meredith Van Dyke, Lihua Wang, Michael E Bose, Marilyn Khanna, Jacob A Metallo, Kelly J Henrickson

Affiliations

  1. Department of Pediatric, Medical College of Wisconsin, Milwaukee, WI 53226, USA; [email protected] (J.H.); [email protected] (A.J.K.); [email protected] (J.F.); [email protected] (M.V.D.); [email protected] (L.W.); [email protected] (M.E.B.); [email protected] (J.A.M.).

PMID: 20224751 PMCID: PMC2836126 DOI: 10.3390/v1030441

Abstract

Assays to simultaneously detect multiple potential agents of bioterrorism are limited. Two multiplex PCR and RT-PCR enzyme hybridization assays (mPCR-EHA, mRT-PCR-EHA) were developed to simultaneously detect many of the CDC category "A" bioterrorism agents. The "Bio T" DNA assay was developed to detect: Variola major (VM), Bacillus anthracis (BA), Yersinia pestis (YP), Francisella tularensis (FT) and Varicella zoster virus (VZV). The "Bio T" RNA assay (mRT-PCR-EHA) was developed to detect: Ebola virus (Ebola), Lassa fever virus (Lassa), Rift Valley fever (RVF), Hantavirus Sin Nombre species (HSN) and dengue virus (serotypes 1-4). Sensitivity and specificity of the 2 assays were tested by using genomic DNA, recombinant plasmid positive controls, RNA transcripts controls, surrogate (spiked) clinical samples and common respiratory pathogens. The analytical sensitivity (limit of detection (LOD)) of the DNA asssay for genomic DNA was 1x10(0)~1x10(2) copies/mL for BA, FT and YP. The LOD for VZV whole organism was 1x10(-2) TCID(50)/mL. The LOD for recombinant controls ranged from 1x10(2)~1x10(3)copies/mL for BA, FT, YP and VM. The RNA assay demonstrated LOD for RNA transcript controls of 1x10(4)~1x10(6) copies/mL without extraction and 1x10(5)~1x10(6) copies/mL with extraction for Ebola, RVF, Lassa and HSN. The LOD for dengue whole organisms was ~1x10(-4) dilution for dengue 1 and 2, 1x10(4) LD(50)/mL and 1x10(2) LD(50)/mL for dengue 3 and 4. The LOD without extraction for recombinant plasmid DNA controls was ~1x10(3) copies/mL (1.5 input copies/reaction) for Ebola, RVF, Lassa and HSN. No cross-reactivity of primers and probes used in both assays was detected with common respiratory pathogens or between targeted analytes. Clinical sensitivity was estimated using 264 surrogate clinical samples tested with the BioT DNA assay and 549 samples tested with the BioT RNA assay. The clinical specificity is 99.6% and 99.8% for BioT DNA assay and BioT RNA assay, respectively. The surrogate sensitivities of these two assays were 100% (95%CI 83-100) for FT, BA (pX02), YP, VM, VZV, dengue 2,3,4 and 95% (95%CI 75-100) for BA (pX01) and dengue 1 using spiked clinical specimens. The specificity of both BioT multiplex assays on spiked specimens was 100% (95% CI 99-100). Compared to other available assays (culture, serology, PCR, etc.) both the BioT DNA mPCR-EHA and BioT RNA mRT-PCR-EHA are rapid, sensitive and specific assays for detecting many category "A" Bioterrorism agents using a standard thermocycler.

References

  1. J Clin Lab Anal. 2007;21(4):244-8 - PubMed
  2. Ann N Y Acad Sci. 1999;894:130-48 - PubMed
  3. Singapore Med J. 2007 Jul;48(7):662-8 - PubMed
  4. Scand J Infect Dis. 2000;32(3):287-91 - PubMed
  5. J Clin Microbiol. 2006 Apr;44(4):1295-304 - PubMed
  6. Trends Microbiol. 2001 Jan;9(1):15-8 - PubMed
  7. Microb Pathog. 1993 May;14(5):381-8 - PubMed
  8. Science. 1999 Feb 26;283(5406):1279-82 - PubMed
  9. J Clin Microbiol. 2001 Aug;39(8):2779-83 - PubMed
  10. J Bacteriol. 1993 Sep;175(17):5329-38 - PubMed
  11. Clin Infect Dis. 1998 Jun;26(6):1397-402 - PubMed
  12. J Med Virol. 2006 Jun;78(6):760-3 - PubMed
  13. Trends Microbiol. 2004 Jun;12(6):259-63 - PubMed
  14. J Clin Microbiol. 2005 Feb;43(2):565-71 - PubMed
  15. Mol Diagn. 2001 Dec;6(4):323-33 - PubMed
  16. J Bacteriol. 1989 Feb;171(2):722-30 - PubMed
  17. Microb Pathog. 1991 Mar;10(3):183-98 - PubMed
  18. Int J Lab Hematol. 2007 Apr;29(2):139-44 - PubMed
  19. Am J Clin Pathol. 2001 Aug;116(2):218-24 - PubMed
  20. Emerg Infect Dis. 1999 Jul-Aug;5(4):537-9 - PubMed
  21. Pediatr Clin North Am. 2006 Oct;53(5):817-42, vii-viii - PubMed
  22. J Clin Microbiol. 2002 Jul;40(7):2323-30 - PubMed
  23. J Microbiol Methods. 2007 Dec;71(3):238-45 - PubMed
  24. J Clin Microbiol. 2006 Aug;44(8):2681-8 - PubMed
  25. J Virol Methods. 1992 Sep;39(1-2):231-5 - PubMed
  26. J Clin Microbiol. 2003 Mar;41(3):1212-8 - PubMed
  27. J Clin Microbiol. 1996 Aug;34(8):1914-7 - PubMed
  28. JAMA. 1997 Aug 6;278(5):399-411 - PubMed
  29. Infect Immun. 1985 Aug;49(2):291-7 - PubMed
  30. J Clin Virol. 2007 Oct;40(2):142-5 - PubMed
  31. Eur J Clin Microbiol Infect Dis. 2007 Mar;26(3):207-11 - PubMed
  32. JAMA. 2001 Feb 28;285(8):1059-70 - PubMed
  33. J Appl Microbiol. 2000 Apr;88(4):648-54 - PubMed
  34. J Clin Microbiol. 2001 Nov;39(11):4119-24 - PubMed

Publication Types

Grant support